Abstract Context Each year the European Association of Urology (EAU) produce a document
based on the most recent evidence on the diagnosis, therapy, and follow-up of testicular …

Abstract The Tumor-Node-Metastasis (TNM) classification on cancer staging, jointly
developed by the American Joint Commission on Cancer (AJCC) and the Union for …

Testicular cancer is the most common malignancy among men between 14 and 44 years of
age, and its incidence has risen over the past two decades in Western countries. Both …

PURPOSE Previous studies suggested that serum levels of microRNA (miR)-371a-3p (so-
called M371 test) have a much higher sensitivity and specificity than the classic markers of …

Abstract The European Society for Medical Oncology (ESMO) consensus conference on
testicular cancer was held on 3–5 November 2016 in Paris, France. The conference …

Purpose: Testis cancer is the most common solid malignancy in young males. The purpose
of this guideline is to provide a useful reference on the effective evidence-based treatment of …

Testicular germ cell tumours are at the crossroads of developmental and neoplastic
processes. Their cause has not been fully elucidated but differences in incidences suggest …

Purpose Cisplatin is widely used but highly ototoxic. Effects of cumulative cisplatin dose on
hearing loss have not been comprehensively evaluated in survivors of adult-onset cancer …

Background Primary retroperitoneal lymph node dissection (RPLND) for clinical stage (CS)
IIA/B seminoma without adjuvant treatment is an experimental treatment to avoid …

In 2016, there were an estimated 8700 new cases of testicular cancer (TC) in the United
States and 380 deaths. 1 Although TC is a rare disease, accounting for only approximately …